Jose Luis Vazquez Martinez

SAMHSA's 2018 National Survey on Drug Use and Health (NSDUH)

 

The 2018 National Survey on Drug Use and Health (NSDUH) data presented by Dr. Elinore F. McCance-Katz, Assistant Secretary for Mental Health and Substance Use.

 

Jose Luis Vazquez Martinez

Source: Armenian P, Whitman JD, Badea A, et al. Notes from the Field: Unintentional Fentanyl Overdoses Among Persons Who Thought They Were Snorting Cocaine — Fresno, California, January 7, 2019. MMWR Morb Mortal Wkly Rep 2019;68:687–688.

Drug-related Deaths and Mortality in Europe: Update from the EMCDDA Expert Network

This publication provides an update on drug-related deaths in Europe, presenting and analysing the latest data and trends in drug-induced deaths and overall mortality among high-risk drug users in the European Union and beyond.

It draws on contributions from specialists representing more than 40 countries at the latest meeting of the EMCDDA expert network on drug-related deaths in November 2018 as well as information provided by European countries in the annual reporting exercise.

Contents

  • Introduction and objective of this report
  • Overdose deaths in Europe: Comparisons and causes
  • Overall mortality: Insights from cohort studies
  • Responding to drug-related deaths
  • The way forward: Exploring complementary sources
  • Conclusions
  • Acknowledgements
  • References
  • Appendix
Jose Luis Vazquez Martinez

Indicadores socioeconómicos entre la población adolescente y joven del Perú

 

Eiji Alfredo Fukushima Taniguchi

Informe que delinea la situación general que guarda el consumo de drogas en México y describe las acciones que actualmente se implementan en el control de la oferta y la reducción de la demanda

World Drug Report 2019

The World Drug Report aims at improving the understanding of the world drug problem and contributing towards fostering greater international cooperation for countering its impact on health, governance and security.

The World Drug Report 2019 is presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history.

Booklet 1- key findings and implications for policy

Booklet 2- a global overview of the latest estimates of and trends in the supply, use and health consequences of drugs

Booklet 3- trends in the market for depressants (including opioids, sedatives, tranquillizers and hypnotics)

Booklet 4- recent trends in the market for stimulants (including cocaine, amphetamine-type stimulants and new psychoactive substances)

Booklet 5- a review of recent trends in the market for cannabis and for hallucinogens

Infographics: European Drug Report 2019

EMCDDA has developed a range of downloadable infographics to illustrate findings from the European Drug Report 2019.

The aim of the report is to provide reliable and detailed evidence of the drug situation in Europes so that practice and new policies can be informed by sound research.

By following trends, conclusions can be drawn and predictions made about how the drug situation might unfold in the future.

GDS 2019 — Key Findings Report

The Global Drug Survey is the Worlds is the worlds largest drug survey. The aim of the GDS is to support communities to have honest and evidence-informed conversations about drugs.

Using anonymous online research methods Global Drug Survey runs an annual survey in 10 languages, which is hosted by partners in over 20 countries.

Survey findings are frank, honest, and revealing and provide a unique insight into personal decision-making about drug use. GDS explores the positives and negatives of drug use and detects new drugs trends as soon as they appear.

15th UKSBM Annual Scientific Meeting

Event Date
City
Bath
Country
United Kingdom

The UK Society for Behaviour Medicine invites all behavioural and public health researchers, clinical practitioners, epidemiologists, health and clinical psychologists, medical sociologists, health economists, nurses, pharmacists and all other colleagues interested in the field of behavioural medicine to participate in the two day meeting from Thursday 16th January - Friday 17th January 2020.

The society is running an open call for contributions from all areas of behavioural medicine, and would particularly welcome the submission of abstracts and symposia that reflect the broad focus of contemporary research in Behavioural Medicine. These may include, but are not limited to;

  • Promoting health behaviour change (physical activity, diet, and alcohol, tobacco and other substance use)
  • Applications of behaviour change theory
  • Healthy ageing
  • Transport, pollution and health
  • Systems approaches to obesity and non-communicable diseases
  • The role of industry in health and health services
  • Evaluating complex interventions
  • Addressing health inequalities through Behavioural Medicine

Rethinking Addiction

Abstract

Addiction is a complex and challenging condition with many contributing factors. Although addictive behaviors appear to be individual choices, behavior alterations cannot be addressed successfully without considering characteristics of the physical and social environments in which individuals live, work, and play. Exposure to chronic psychosocial stressors and the physiological response of individuals to their external environment activates the brain’s neuroendocrine hypothalamic-pituitary-adrenal axis, with profound conditioning effects on behavior. This brief synopsis describes the social determinants of health; examines the interconnectedness of the psychosocial environment, behavior, and subsequent health outcomes; discusses the environment’s critical influence on brain plasticity, adaptation and functioning; and explores additional factors that complicate adolescent addiction. Because the environment is both a determinant of behavior and an opportunity for intervention, in the context of addictions, it is important to incorporate these factors in the analysis of risk and design of early interventions for prevention and amelioration of addiction.